Product Information
EVEROLIMUS 0.5 MG TABLET is a generic product labeled by Par Health USA, LLC, priced at $3.6886 per EA under NDC 49884015902. Its NADAC has been published 162 times since May 24, 2023.
Strength
.5 mg/1
Manufacturer
Par Health USA, LLCNDC
49884015902
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA205775On Market Since
3/31/2022
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 0.5 MG TABLET has been published 162 times since May 24, 2023, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6886 per EA |
|---|---|
| All-time high | $10.1199 (Apr 10, 2024) |
| All-time low | $3.6048 (May 20, 2026) |
| 52-week high | $4.9030 |
| 52-week low | $3.6048 |
| Median price | $4.8878 |
| Average price | $5.2172 |
| Largest weekly change | +47.4% (Mar 20, 2024) |
| Weeks tracked | 162 |
| Tracking since | May 24, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.5 MG TABLET, manufactured by Par Health USA, LLC, is $3.6886 per EA (NDC 49884015902), effective Jun 24, 2026.
How has the price of EVEROLIMUS 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 0.5 MG TABLET has declined 27.3%. It has been tracked across 162 weekly CMS publications since May 24, 2023.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.5 MG TABLET?
Since May 24, 2023, the NADAC for EVEROLIMUS 0.5 MG TABLET has ranged from a low of $3.6048 (May 20, 2026) to a high of $10.1199 (Apr 10, 2024), with a median of $4.8878 per EA.
Are there cheaper alternatives to EVEROLIMUS 0.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as EVEROLIMUS 0.5 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 0.5 MG TABLET?
EVEROLIMUS 0.5 MG TABLET (NDC 49884015902) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification